Blog
Defense Secretary Pledges to Add Billions to Navy Shipbuilding Budget
Secretary of Defense Mark Esper provided a rare piece of good news for U.S. shipbuilders Wednesday, saying he was committed to increasing funding for new ships as the Navy revs up for a new arms
This Chilling Forecast Will Send Shivers Across the Oil Patch
For decades, the global economy had a nearly insatiable appetite for crude oil. That caused consumption to steadily march higher, peaking at more than 100 million barrels per day (BPD) in the past
Planning to Work After Claiming Social Security? Here's What You Need to Know
Though Social Security serves as a steady source of income for millions of seniors, many can't live on those benefits alone. Rather, they need additional income to cover their expenses, whether it
3 Semiconductor Stocks to Buy if the Market Crashes
Investing in semiconductor stocks can be challenging. As with all things rooted in manufacturing, the fortunes of chipmakers are highly sensitive to supply and demand. After a rough go in 2018
Now We Know Who at Berkshire Invested in Snowflake, and Why
The hottest IPO of the year is cloud-based data warehouse provider Snowflake (NYSE: SNOW). It was initially slated to go public at $75 to $85 per share last Wednesday, but interest in the stock was
3 Energy Stocks to Buy Right Now
The energy industry has changed rapidly over the last decade as oil and natural gas investments have struggled and renewable energy and electric vehicle (EV) production has exploded. You can see
6 Unexpected Sources of Retirement Income
Retirement should be your time to relax and enjoy life, without alarm clocks and meetings. Unfortunately, saying goodbye to your boss also involves saying goodbye to your paycheck.
If you haven't
Where Will Electric Vehicles Be in 5 Years?
For years, scrappy little Tesla (NASDAQ: TSLA) was the only electric vehicle stock out there... with analysts constantly predicting its demise. Today, it's the largest car company in the world by
Rolling Stone and Fidelity Take a Stand in Trump's Battle Against ESG Funds
There's a battle going on, and it could affect the future of investment options in your 401(k). The Department of Labor (DOL) under President Trump has taken a stand to keep ESG funds out of
What's Wrong With Charlotte's Web?
Charlotte's Web (OTC: CWBHF) was supposed to be a safe bet. Its hemp-based products are federally legal (unlike their cousin, marijuana), and consumers can buy them at more than 21,000 retail
3 Dividend Stocks to Buy on Sale
One of the best reasons to buy dividend stocks on sale is that a cheaper price means better-than-normal yields. A stock's price is inversely related to its dividend yield, and that means not only
3 Stocks Under $10 Ready to Break Out in 2021
Big gains can come from stocks with small share prices, but the catalysts have to be there. A lot of speculators will lose their shirts chasing penny stocks without doing any research, but there are
3 Things to Watch For Before You Buy Aurora Cannabis Stock
Aurora Cannabis (NYSE: ACB), once a favorite among pot investors because of its bold expansion strategy, lost steam in 2019. Aurora's shares declined 56% last year, compared to a 36% decline of the
3 Things IBM Wants You to Know About Its Cloud Strategy
International Business Machines (NYSE: IBM) has long been a prominent name in the technology industry. However, the tech stock has suffered in recent years as many of its divisions have seen steady
What Can Investors Learn From the Explosion of IPOs?
In August, a number of popular tech companies announced plans for their initial public offerings (IPO). This is exciting for many investors who are looking for more opportunities in the technology
4 Must-Have Documents for a Peaceful Retirement
Most people can't wait for retirement, and even more would likely opt for some form of early retirement if they had the opportunity. Whenever you ultimately decide to cut down your time at work or
3 Top Biotech Picks for 2025
When it comes to astronomical returns in investing, one of the most important factors -- aside from buying the right company -- is buying your shares early, when ordinary people have never heard of
Market Crash 2.0: 2 Stocks to Buy Right Now to Keep Your Portfolio Safe
The last time there was a market crash, it was COVID-19-related concerns that sent investors into a panic. While the markets have recovered since then, amidst uncertainty about the strength of the
These 3 Stocks Could Soar if Biden Beats Trump
The U.S. election on Nov. 3 could bring a change to the highest office in the land and create new opportunities for some promising companies. We asked three Motley Fool contributors to profile a sto
Here's Why Municipal Bonds Belong in Every Investor's Portfolio
You'll often hear that to grow serious wealth, you can't tie up the bulk of your money in bonds. The reason? Though stocks are more volatile than bonds, they tend to deliver a much higher return on
3 Compelling Biotech Stocks to Consider Buying While They're Hot on Robinhood
Traders on the Robinhood investing app are notorious for picking highly speculative stocks -- and as a group, they're too powerful to ignore if you're considering an investment in smaller biotech
3 Software Stocks Share This 1 Key to Success
Would you buy a car without driving it first? I'm sure it happens, but I can't imagine anyone who would do so by choice. Buying software is no different. Before they buy, most users want to
3 Companies Tesla Should Be Worried About in 2021
Tesla's (NASDAQ: TSLA) market cap has surged to over $400 billion in 2020 as investors have bought into everything from Tesla's growth to its future as an auto technology company. And with
New Retirees Better Prepare for 25% Smaller Social Security Checks at 73
Social Security has long been one of the most important sources of income that retirees receive. But while these benefits should provide a reliable, steady source of funds that are guaranteed for
Does Cassava Sciences Have the Alzheimer's Disease Drug We've Been Waiting For?
Shares of Cassava Sciences (NASDAQ: SAVA) rocketed higher last week in response to compelling results from a clinical trial with sumifilam, an experimental treatment for Alzheimer's patients. This


